UnitedHealth Group (UNH) Competitors

$487.30
+1.12 (+0.23%)
(As of 04/24/2024 ET)

UNH vs. ELV, JNJ, NVO, MRK, ABBV, AZN, LLY, TMO, NVS, and ABT

Should you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Elevance Health (ELV), Johnson & Johnson (JNJ), Novo Nordisk A/S (NVO), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), Eli Lilly and Company (LLY), Thermo Fisher Scientific (TMO), Novartis (NVS), and Abbott Laboratories (ABT). These companies are all part of the "medical" sector.

UnitedHealth Group vs.

UnitedHealth Group (NYSE:UNH) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, community ranking, valuation, dividends and risk.

UnitedHealth Group received 838 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 80.50% of users gave UnitedHealth Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
UnitedHealth GroupOutperform Votes
1668
80.50%
Underperform Votes
404
19.50%
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%

In the previous week, UnitedHealth Group had 19 more articles in the media than Elevance Health. MarketBeat recorded 78 mentions for UnitedHealth Group and 59 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.77 beat UnitedHealth Group's score of 0.48 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
21 Very Positive mention(s)
14 Positive mention(s)
23 Neutral mention(s)
8 Negative mention(s)
1 Very Negative mention(s)
Neutral
Elevance Health
21 Very Positive mention(s)
6 Positive mention(s)
16 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group currently has a consensus price target of $570.05, indicating a potential upside of 16.98%. Elevance Health has a consensus price target of $587.42, indicating a potential upside of 10.05%. Given UnitedHealth Group's higher possible upside, equities analysts clearly believe UnitedHealth Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92

UnitedHealth Group has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$371.62B1.21$22.38B$16.3629.79
Elevance Health$171.75B0.72$5.99B$26.4620.17

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of UnitedHealth Group shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

UnitedHealth Group pays an annual dividend of $7.52 per share and has a dividend yield of 1.5%. Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. UnitedHealth Group pays out 46.0% of its earnings in the form of a dividend. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

UnitedHealth Group has a net margin of 4.05% compared to Elevance Health's net margin of 3.64%. UnitedHealth Group's return on equity of 26.50% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group4.05% 26.50% 8.60%
Elevance Health 3.64%20.62%7.35%

Summary

UnitedHealth Group beats Elevance Health on 14 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$449.26B$65.37B$4.90B$17.42B
Dividend Yield1.53%1.36%2.97%3.56%
P/E Ratio29.7920.21259.1425.15
Price / Sales1.210.512,391.1211.62
Price / Cash16.5010.3246.7317.62
Price / Book4.863.474.664.91
Net Income$22.38B$3.04B$103.36M$964.49M
7 Day Performance-1.19%2.27%0.33%2.27%
1 Month Performance0.28%-0.83%-5.22%-2.07%
1 Year Performance-0.94%15.32%9.08%91.79%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.8311 of 5 stars
$532.17
+0.1%
$587.64
+10.4%
+15.3%$123.69B$171.34B20.11104,900Earnings Report
Dividend Announcement
Analyst Report
Analyst Revision
JNJ
Johnson & Johnson
4.8981 of 5 stars
$149.12
+0.8%
$175.86
+17.9%
-9.3%$359.35B$85.16B9.30131,900Options Volume
NVO
Novo Nordisk A/S
3.0573 of 5 stars
$125.23
+2.1%
$133.60
+6.7%
+196.1%$561.97B$33.71B46.3063,370Upcoming Earnings
MRK
Merck & Co., Inc.
4.8261 of 5 stars
$126.94
+0.9%
$131.25
+3.4%
+9.5%$321.54B$60.12B906.7172,000Analyst Revision
ABBV
AbbVie
4.928 of 5 stars
$167.94
+0.9%
$177.43
+5.6%
+2.3%$297.36B$54.32B61.5250,000Upcoming Earnings
AZN
AstraZeneca
3.3347 of 5 stars
$70.13
+2.3%
$80.00
+14.1%
-6.1%$217.43B$45.81B36.5389,900
LLY
Eli Lilly and Company
4.8377 of 5 stars
$731.32
+0.7%
$728.05
-0.4%
+91.0%$694.87B$34.12B126.0943,000Upcoming Earnings
TMO
Thermo Fisher Scientific
4.8949 of 5 stars
$548.37
+0.7%
$604.69
+10.3%
+0.6%$209.32B$42.86B35.49122,000News Coverage
NVS
Novartis
2.6838 of 5 stars
$95.11
+0.8%
$114.00
+19.9%
-2.2%$194.40B$45.44B13.2576,057Analyst Report
Analyst Revision
News Coverage
Gap Up
ABT
Abbott Laboratories
4.9909 of 5 stars
$107.07
-0.2%
$121.90
+13.9%
-3.2%$186.15B$40.33B33.36114,000Analyst Report
Analyst Revision

Related Companies and Tools

This page (NYSE:UNH) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners